These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 16818949

  • 1. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.
    Lantry LE, Cappelletti E, Maddalena ME, Fox JS, Feng W, Chen J, Thomas R, Eaton SM, Bogdan NJ, Arunachalam T, Reubi JC, Raju N, Metcalfe EC, Lattuada L, Linder KE, Swenson RE, Tweedle MF, Nunn AD.
    J Nucl Med; 2006 Jul; 47(7):1144-52. PubMed ID: 16818949
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN).
    Wild D, Frischknecht M, Zhang H, Morgenstern A, Bruchertseifer F, Boisclair J, Provencher-Bolliger A, Reubi JC, Maecke HR.
    Cancer Res; 2011 Feb 01; 71(3):1009-18. PubMed ID: 21245097
    [Abstract] [Full Text] [Related]

  • 5. In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues.
    Thomas R, Chen J, Roudier MM, Vessella RL, Lantry LE, Nunn AD.
    Clin Exp Metastasis; 2009 Feb 01; 26(2):105-19. PubMed ID: 18975117
    [Abstract] [Full Text] [Related]

  • 6. Automated synthesis, characterization and biological evaluation of [(68)Ga]Ga-AMBA, and the synthesis and characterization of (nat)Ga-AMBA and [(67)Ga]Ga-AMBA.
    Cagnolini A, Chen J, Ramos K, Skedzielewski TM, Lantry LE, Nunn AD, Swenson RE, Linder KE.
    Appl Radiat Isot; 2010 Dec 01; 68(12):2285-92. PubMed ID: 20638858
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor.
    Ma L, Yu P, Veerendra B, Rold TL, Retzloff L, Prasanphanich A, Sieckman G, Hoffman TJ, Volkert WA, Smith CJ.
    Mol Imaging; 2007 Dec 01; 6(3):171-80. PubMed ID: 17532883
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
    de Visser M, van Weerden WM, de Ridder CM, Reneman S, Melis M, Krenning EP, de Jong M.
    J Nucl Med; 2007 Jan 01; 48(1):88-93. PubMed ID: 17204703
    [Abstract] [Full Text] [Related]

  • 12. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.
    Markwalder R, Reubi JC.
    Cancer Res; 1999 Mar 01; 59(5):1152-9. PubMed ID: 10070977
    [Abstract] [Full Text] [Related]

  • 13. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14).
    Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC, Gugger M.
    Clin Cancer Res; 2002 Apr 01; 8(4):1139-46. PubMed ID: 11948125
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, stabilization and formulation of [177Lu]Lu-AMBA, a systemic radiotherapeutic agent for Gastrin Releasing Peptide receptor positive tumors.
    Chen J, Linder KE, Cagnolini A, Metcalfe E, Raju N, Tweedle MF, Swenson RE.
    Appl Radiat Isot; 2008 Apr 01; 66(4):497-505. PubMed ID: 18178448
    [Abstract] [Full Text] [Related]

  • 15. Isolation of a 177Hf complex formed by beta-decay of a 177Lu-labeled radiotherapeutic compound and NMR structural elucidation of the ligand and its Lu and Hf complexes.
    Cagnolini A, D'Amelio N, Metcalfe E, Nguyen HD, Aime S, Swenson RE, Linder KE.
    Inorg Chem; 2009 Apr 06; 48(7):3114-24. PubMed ID: 19243162
    [Abstract] [Full Text] [Related]

  • 16. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
    Däpp S, García Garayoa E, Maes V, Brans L, Tourwé DA, Müller C, Schibli R.
    Nucl Med Biol; 2011 Oct 06; 38(7):997-1009. PubMed ID: 21982571
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effect of antagonists of bombesin and growth hormone-releasing hormone on orthotopic and intraosseous growth and invasiveness of PC-3 human prostate cancer in nude mice.
    Stangelberger A, Schally AV, Varga JL, Zarandi M, Szepeshazi K, Armatis P, Halmos G.
    Clin Cancer Res; 2005 Jan 01; 11(1):49-57. PubMed ID: 15671527
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.
    Mansi R, Wang X, Forrer F, Kneifel S, Tamma ML, Waser B, Cescato R, Reubi JC, Maecke HR.
    Clin Cancer Res; 2009 Aug 15; 15(16):5240-9. PubMed ID: 19671861
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S, Wuest M, Krieger SS, Rogers BE, Friebe M, Bergmann R, Wuest F.
    Nucl Med Biol; 2013 Nov 15; 40(8):1025-34. PubMed ID: 23969085
    [Abstract] [Full Text] [Related]

  • 20. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.
    Int J Pharm; 2009 Jun 22; 375(1-2):75-83. PubMed ID: 19393305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.